Population Pharmacokinetics of High Dose Continuous Infusion Meropenem and Considerations for the Use in the Treatment of Infections due to KPC-Producing Klebsiella pneumoniae.

about

Population Pharmacokinetics of High Dose Continuous Infusion Meropenem and Considerations for the Use in the Treatment of Infections due to KPC-Producing Klebsiella pneumoniae.

Item

http://www.wikidata.org/entity/Q40112541

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Population Pharmacokinetics of ...... oducing Klebsiella pneumoniae.

@en

type

Item

label

Population Pharmacokinetics of ...... oducing Klebsiella pneumoniae.

@en

prefLabel

Population Pharmacokinetics of ...... oducing Klebsiella pneumoniae.

@en

P1476

Population Pharmacokinetics of ...... oducing Klebsiella pneumoniae.

@en

P2093

Assunta Sartor

http://www.w3.org/2001/XMLSchema#string

Claudio Scarparo

http://www.w3.org/2001/XMLSchema#string

Federico Pea

http://www.w3.org/2001/XMLSchema#string

Piergiorgio Cojutti

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of creatinine clearance from serum creatinine

Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.

Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.

Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrations.

Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.

Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest.

Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

Global spread of Carbapenemase-producing Enterobacteriaceae

P31

scholarly article

P356

10.1128/AAC.00794-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elda Righi

Matteo Bassetti

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28760900

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

P932

5610526

http://www.w3.org/2001/XMLSchema#string